nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A1—Lisinopril—dilated cardiomyopathy	0.799	1	CbGbCtD
Cefuroxime—Drug fever—Spironolactone—dilated cardiomyopathy	0.0129	0.068	CcSEcCtD
Cefuroxime—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00733	0.0386	CcSEcCtD
Cefuroxime—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.00653	0.0344	CcSEcCtD
Cefuroxime—Local reaction—Furosemide—dilated cardiomyopathy	0.00423	0.0223	CcSEcCtD
Cefuroxime—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00347	0.0183	CcSEcCtD
Cefuroxime—Renal pain—Lisinopril—dilated cardiomyopathy	0.00335	0.0176	CcSEcCtD
Cefuroxime—Cholestasis—Furosemide—dilated cardiomyopathy	0.00309	0.0163	CcSEcCtD
Cefuroxime—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00306	0.0161	CcSEcCtD
Cefuroxime—Injection site pain—Furosemide—dilated cardiomyopathy	0.00287	0.0151	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00282	0.0148	CcSEcCtD
Cefuroxime—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00282	0.0148	CcSEcCtD
Cefuroxime—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00268	0.0141	CcSEcCtD
Cefuroxime—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00241	0.0127	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00239	0.0126	CcSEcCtD
Cefuroxime—Renal failure—Spironolactone—dilated cardiomyopathy	0.00237	0.0125	CcSEcCtD
Cefuroxime—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00225	0.0119	CcSEcCtD
Cefuroxime—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0022	0.0116	CcSEcCtD
Cefuroxime—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00205	0.0108	CcSEcCtD
Cefuroxime—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00197	0.0104	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00189	0.00994	CcSEcCtD
Cefuroxime—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00185	0.00974	CcSEcCtD
Cefuroxime—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00181	0.00955	CcSEcCtD
Cefuroxime—Thirst—Furosemide—dilated cardiomyopathy	0.00179	0.00942	CcSEcCtD
Cefuroxime—Cephaloglycin—SLC22A5—dilated cardiomyopathy	0.00175	0.161	CrCbGaD
Cefuroxime—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00171	0.009	CcSEcCtD
Cefuroxime—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00169	0.00889	CcSEcCtD
Cefuroxime—Cefepime—SLC22A5—dilated cardiomyopathy	0.00166	0.152	CrCbGaD
Cefuroxime—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00166	0.00875	CcSEcCtD
Cefuroxime—Irritability—Furosemide—dilated cardiomyopathy	0.00162	0.00856	CcSEcCtD
Cefuroxime—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00159	0.0084	CcSEcCtD
Cefuroxime—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00154	0.0081	CcSEcCtD
Cefuroxime—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00153	0.00808	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00153	0.00808	CcSEcCtD
Cefuroxime—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00151	0.00793	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00146	0.0077	CcSEcCtD
Cefuroxime—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00146	0.00768	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00141	0.00745	CcSEcCtD
Cefuroxime—Somnolence—Spironolactone—dilated cardiomyopathy	0.00137	0.0072	CcSEcCtD
Cefuroxime—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00134	0.00707	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00133	0.007	CcSEcCtD
Cefuroxime—Drowsiness—Furosemide—dilated cardiomyopathy	0.00131	0.00691	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0013	0.00685	CcSEcCtD
Cefuroxime—Cefixime—SLC22A5—dilated cardiomyopathy	0.0013	0.119	CrCbGaD
Cefuroxime—Renal failure—Furosemide—dilated cardiomyopathy	0.00129	0.00679	CcSEcCtD
Cefuroxime—Sweating—Furosemide—dilated cardiomyopathy	0.00126	0.00663	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00124	0.00654	CcSEcCtD
Cefuroxime—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00122	0.00645	CcSEcCtD
Cefuroxime—Ceftazidime—SLC22A5—dilated cardiomyopathy	0.00122	0.112	CrCbGaD
Cefuroxime—Urticaria—Spironolactone—dilated cardiomyopathy	0.00122	0.00644	CcSEcCtD
Cefuroxime—Irritability—Lisinopril—dilated cardiomyopathy	0.00122	0.00642	CcSEcCtD
Cefuroxime—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00122	0.00641	CcSEcCtD
Cefuroxime—Cefdinir—SLC22A5—dilated cardiomyopathy	0.0012	0.11	CrCbGaD
Cefuroxime—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.0012	0.0063	CcSEcCtD
Cefuroxime—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00116	0.00613	CcSEcCtD
Cefuroxime—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00115	0.00608	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00115	0.00606	CcSEcCtD
Cefuroxime—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00115	0.00606	CcSEcCtD
Cefuroxime—Cefradine—SLC22A5—dilated cardiomyopathy	0.00114	0.105	CrCbGaD
Cefuroxime—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00113	0.00597	CcSEcCtD
Cefuroxime—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00111	0.00587	CcSEcCtD
Cefuroxime—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00109	0.00576	CcSEcCtD
Cefuroxime—Pruritus—Spironolactone—dilated cardiomyopathy	0.00109	0.00573	CcSEcCtD
Cefuroxime—Cefadroxil—SLC22A5—dilated cardiomyopathy	0.00108	0.0989	CrCbGaD
Cefuroxime—Angiopathy—Furosemide—dilated cardiomyopathy	0.00107	0.00563	CcSEcCtD
Cefuroxime—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00106	0.0056	CcSEcCtD
Cefuroxime—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00559	CcSEcCtD
Cefuroxime—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00105	0.00554	CcSEcCtD
Cefuroxime—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00105	0.00552	CcSEcCtD
Cefuroxime—Dysuria—Lisinopril—dilated cardiomyopathy	0.00103	0.00544	CcSEcCtD
Cefuroxime—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00103	0.00544	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00103	0.00541	CcSEcCtD
Cefuroxime—Erythema—Furosemide—dilated cardiomyopathy	0.00102	0.0054	CcSEcCtD
Cefuroxime—Dizziness—Spironolactone—dilated cardiomyopathy	0.00102	0.00536	CcSEcCtD
Cefuroxime—Flatulence—Furosemide—dilated cardiomyopathy	0.00101	0.00532	CcSEcCtD
Cefuroxime—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000985	0.00519	CcSEcCtD
Cefuroxime—Vomiting—Spironolactone—dilated cardiomyopathy	0.000978	0.00515	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000976	0.00514	CcSEcCtD
Cefuroxime—Rash—Spironolactone—dilated cardiomyopathy	0.000969	0.00511	CcSEcCtD
Cefuroxime—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000968	0.0051	CcSEcCtD
Cefuroxime—Renal failure—Lisinopril—dilated cardiomyopathy	0.000967	0.0051	CcSEcCtD
Cefuroxime—Headache—Spironolactone—dilated cardiomyopathy	0.000963	0.00508	CcSEcCtD
Cefuroxime—Jaundice—Lisinopril—dilated cardiomyopathy	0.000959	0.00506	CcSEcCtD
Cefuroxime—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000957	0.00504	CcSEcCtD
Cefuroxime—Sweating—Lisinopril—dilated cardiomyopathy	0.000943	0.00497	CcSEcCtD
Cefuroxime—Agitation—Furosemide—dilated cardiomyopathy	0.000942	0.00496	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000931	0.00491	CcSEcCtD
Cefuroxime—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000923	0.00487	CcSEcCtD
Cefuroxime—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000918	0.00484	CcSEcCtD
Cefuroxime—Leukopenia—Furosemide—dilated cardiomyopathy	0.000917	0.00484	CcSEcCtD
Cefuroxime—Nausea—Spironolactone—dilated cardiomyopathy	0.000913	0.00481	CcSEcCtD
Cefuroxime—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000883	0.00466	CcSEcCtD
Cefuroxime—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000872	0.0046	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000867	0.00457	CcSEcCtD
Cefuroxime—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000866	0.00456	CcSEcCtD
Cefuroxime—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000836	0.00441	CcSEcCtD
Cefuroxime—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000835	0.0044	CcSEcCtD
Cefuroxime—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000819	0.00432	CcSEcCtD
Cefuroxime—Skin disorder—Furosemide—dilated cardiomyopathy	0.000812	0.00428	CcSEcCtD
Cefuroxime—Cefalotin—SLC22A5—dilated cardiomyopathy	0.000811	0.0744	CrCbGaD
Cefuroxime—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000809	0.00426	CcSEcCtD
Cefuroxime—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000801	0.00422	CcSEcCtD
Cefuroxime—Anorexia—Furosemide—dilated cardiomyopathy	0.000797	0.0042	CcSEcCtD
Cefuroxime—Chills—Lisinopril—dilated cardiomyopathy	0.000793	0.00418	CcSEcCtD
Cefuroxime—Erythema—Lisinopril—dilated cardiomyopathy	0.000769	0.00405	CcSEcCtD
Cefuroxime—Flatulence—Lisinopril—dilated cardiomyopathy	0.000758	0.00399	CcSEcCtD
Cefuroxime—Somnolence—Furosemide—dilated cardiomyopathy	0.000744	0.00392	CcSEcCtD
Cefuroxime—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000739	0.0039	CcSEcCtD
Cefuroxime—Cephalexin—SLC22A5—dilated cardiomyopathy	0.000737	0.0677	CrCbGaD
Cefuroxime—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000727	0.00383	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000722	0.00381	CcSEcCtD
Cefuroxime—Pain—Furosemide—dilated cardiomyopathy	0.000715	0.00377	CcSEcCtD
Cefuroxime—Angioedema—Lisinopril—dilated cardiomyopathy	0.000703	0.0037	CcSEcCtD
Cefuroxime—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000688	0.00363	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000684	0.0036	CcSEcCtD
Cefuroxime—Palpitations—Lisinopril—dilated cardiomyopathy	0.00068	0.00358	CcSEcCtD
Cefuroxime—Cough—Lisinopril—dilated cardiomyopathy	0.000671	0.00354	CcSEcCtD
Cefuroxime—Urticaria—Furosemide—dilated cardiomyopathy	0.000664	0.0035	CcSEcCtD
Cefuroxime—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000661	0.00349	CcSEcCtD
Cefuroxime—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000661	0.00349	CcSEcCtD
Cefuroxime—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000655	0.00345	CcSEcCtD
Cefuroxime—Chest pain—Lisinopril—dilated cardiomyopathy	0.000655	0.00345	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00065	0.00343	CcSEcCtD
Cefuroxime—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000628	0.00331	CcSEcCtD
Cefuroxime—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000616	0.00325	CcSEcCtD
Cefuroxime—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000614	0.00324	CcSEcCtD
Cefuroxime—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000613	0.00323	CcSEcCtD
Cefuroxime—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00061	0.00321	CcSEcCtD
Cefuroxime—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000607	0.0032	CcSEcCtD
Cefuroxime—Anorexia—Lisinopril—dilated cardiomyopathy	0.000598	0.00315	CcSEcCtD
Cefuroxime—Pruritus—Furosemide—dilated cardiomyopathy	0.000592	0.00312	CcSEcCtD
Cefuroxime—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000572	0.00302	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000572	0.00301	CcSEcCtD
Cefuroxime—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00056	0.00295	CcSEcCtD
Cefuroxime—Somnolence—Lisinopril—dilated cardiomyopathy	0.000558	0.00294	CcSEcCtD
Cefuroxime—Dizziness—Furosemide—dilated cardiomyopathy	0.000553	0.00292	CcSEcCtD
Cefuroxime—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000552	0.00291	CcSEcCtD
Cefuroxime—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000546	0.00288	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000542	0.00286	CcSEcCtD
Cefuroxime—Pain—Lisinopril—dilated cardiomyopathy	0.000537	0.00283	CcSEcCtD
Cefuroxime—Vomiting—Furosemide—dilated cardiomyopathy	0.000532	0.0028	CcSEcCtD
Cefuroxime—Rash—Furosemide—dilated cardiomyopathy	0.000527	0.00278	CcSEcCtD
Cefuroxime—Dermatitis—Furosemide—dilated cardiomyopathy	0.000527	0.00278	CcSEcCtD
Cefuroxime—Headache—Furosemide—dilated cardiomyopathy	0.000524	0.00276	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000513	0.0027	CcSEcCtD
Cefuroxime—Urticaria—Lisinopril—dilated cardiomyopathy	0.000499	0.00263	CcSEcCtD
Cefuroxime—Nausea—Furosemide—dilated cardiomyopathy	0.000497	0.00262	CcSEcCtD
Cefuroxime—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000496	0.00261	CcSEcCtD
Cefuroxime—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000496	0.00261	CcSEcCtD
Cefuroxime—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000462	0.00244	CcSEcCtD
Cefuroxime—Pruritus—Lisinopril—dilated cardiomyopathy	0.000444	0.00234	CcSEcCtD
Cefuroxime—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000429	0.00226	CcSEcCtD
Cefuroxime—Dizziness—Lisinopril—dilated cardiomyopathy	0.000415	0.00219	CcSEcCtD
Cefuroxime—Vomiting—Lisinopril—dilated cardiomyopathy	0.000399	0.0021	CcSEcCtD
Cefuroxime—Rash—Lisinopril—dilated cardiomyopathy	0.000396	0.00209	CcSEcCtD
Cefuroxime—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000395	0.00208	CcSEcCtD
Cefuroxime—Headache—Lisinopril—dilated cardiomyopathy	0.000393	0.00207	CcSEcCtD
Cefuroxime—Nausea—Lisinopril—dilated cardiomyopathy	0.000373	0.00196	CcSEcCtD
